SENSEI BIOTHERAPEUTICS INC's ticker is SNSE and the CUSIP is 81728A108. A total of 32 filers reported holding SENSEI BIOTHERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $0 | -100.0% | 247 | -47.7% | 0.00% | – |
Q2 2023 | $1,000 | – | 472 | +673.8% | 0.00% | – |
Q1 2023 | $0 | – | 61 | +1425.0% | 0.00% | – |
Q4 2022 | $0 | – | 4 | -94.8% | 0.00% | – |
Q3 2022 | $0 | -100.0% | 77 | -94.0% | 0.00% | – |
Q1 2022 | $3,000 | -88.5% | 1,284 | -70.4% | 0.00% | – |
Q4 2021 | $26,000 | +4.0% | 4,343 | +80.1% | 0.00% | – |
Q3 2021 | $25,000 | +257.1% | 2,411 | +255.1% | 0.00% | – |
Q2 2021 | $7,000 | -36.4% | 679 | -7.6% | 0.00% | – |
Q1 2021 | $11,000 | – | 735 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alpha Wave Global, LP | 213,658 | $3,104,000 | 0.19% |
Serengeti Asset Management LP | 20,000 | $291,000 | 0.13% |
FORMULA GROWTH LTD | 56,276 | $818,000 | 0.12% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 375,000 | $5,449,000 | 0.12% |
TUDOR INVESTMENT CORP ET AL | 113,353 | $1,647,000 | 0.03% |
Duquesne Family Office | 100,000 | $1,453,000 | 0.03% |
PURA VIDA INVESTMENTS, LLC | 67,357 | $941,000 | 0.03% |
MOORE CAPITAL MANAGEMENT, LP | 127,500 | $1,853,000 | 0.02% |
Zimmer Partners, LP | 46,000 | $668,000 | 0.01% |
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 26,000 | $376,000 | 0.00% |